RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |
Bellevue Group AG | 4,885,000 | $41,082,850 | 0.66% |
Fernwood Investment Management, LLC | 185,063 | $1,556,380 | 0.56% |
Perceptive Advisors | 1,943,097 | $16,341,445 | 0.54% |
BVF INC/IL | 2,365,805 | $19,896,420 | 0.54% |
BRANDYWINE MANAGERS, LLC | 31,807 | $267,497 | 0.45% |
ArrowMark Colorado Holdings LLC | 3,810,579 | $32,046,969 | 0.39% |
Capital Impact Advisors, LLC | 24,117 | $202,824 | 0.34% |
Rhenman & Partners Asset Management AB | 190,000 | $1,597,900 | 0.17% |
Corton Capital Inc. | 39,402 | $331,371 | 0.17% |
Rock Springs Capital Management LP | 673,966 | $5,668,054 | 0.15% |
External links
This page lists RELAY THERAPEUTICS INC's shareholders in Q3 2023. To view RELAY THERAPEUTICS INC's shareholder history, click here.